Enhanced ATPase activities as a primary defect of mutant valosin‐containing proteins that cause inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia
Authors:
Open Access
- 5 July 2010
- journal article
- Published by Wiley in Genes to Cells
- Vol. 15 (8) , 911-922
Abstract
Valosin‐containing protein (VCP) has been shown to colocalize with abnormal protein aggregates, such as nuclear inclusions of Huntington disease and Machado‐Joseph disease, Lewy bodies in Parkinson disease. Several mis‐sense mutations in the human VCP gene have been identified in patients suffering inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia (IBMPFD). Recently, we have shown that VCP possesses both aggregate‐forming and aggregate‐clearing activities. Here, we showed that in cells treated with proteasome inhibitors VCP first appeared as several small aggregates throughout the cells; and then, these small aggregates gathered together into a single big aggregate. Subcellular localization and ATPase activity of VCP clearly influenced the localization of the aggregates. Furthermore, all tested IBMPFD‐causing mutant VCPs, possessed elevated ATPase activities and enhanced aggregate‐forming activities in cultured cells. In Drosophila, these mutants and VCP(T761E), a super active VCP, did not appear to spontaneously induce eye degeneration, but worsened the phenotype when co‐expressed with polyglutamines. Unexpectedly, these VCPs did not apparently change sizes and the amounts of polyglutamine aggregates in Drosophila eyes. Elevated ATPase activities, thus, may be a hidden primary defect causing IBMPFD pathological phenotypes, which would be revealed when abnormal proteins are accumulated, as typically observed in aging.Keywords
This publication has 36 references indexed in Scilit:
- Transgenic mice expressing mutant forms VCP/p97 recapitulate the full spectrum of IBMPFD including degeneration in muscle, brain and boneHuman Molecular Genetics, 2010
- A novel mutation in the VCP gene (G157R) in a german family with inclusion‐body myopathy with paget disease of bone and frontotemporal dementiaMuscle & Nerve, 2009
- Novel Ubiquitin Neuropathology in Frontotemporal Dementia WithValosin-Containing ProteinGene MutationsJournal of Neuropathology & Experimental Neurology, 2006
- Inclusion body myopathy and Paget disease is linked to a novel mutation in the VCP geneNeurology, 2005
- p97 and close encounters of every kind: a brief reviewBiochemical Society Transactions, 2004
- NSF and p97/VCP: similar at first, different at lastFEBS Letters, 2003
- Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegenerationCell Death & Differentiation, 2002
- VCP/p97 in abnormal protein aggregates, cytoplasmic vacuoles, and cell death, phenotypes relevant to neurodegenerationCell Death & Differentiation, 2001
- Membrane TrafficCell, 2001
- Characterization and Dynamics of Aggresome Formation by a Cytosolic Gfp-Chimera✪Journal of Cell Biology, 1999